Showing 31 - 40 of 152
Persistent link: https://www.econbiz.de/10011863565
We construct a structural model of entry into self-employment to evaluate the impact of policies supporting entrepreneurship. Previous work has recognized that workers may opt for self-employment due to the nonpecuniary benefits of running a business and not necessarily because they are good at...
Persistent link: https://www.econbiz.de/10012042451
We examine whether medical innovation can reinforce existing health disparities by disproportionately benefiting socioeconomically advantaged patients. The reason is that less advantaged patients often do not use new medications. This may be due to high costs of new drugs, but could also reflect...
Persistent link: https://www.econbiz.de/10012533413
Persistent link: https://www.econbiz.de/10011953619
We combine state minimum wage changes with individual-level income and credit data to estimate the effect of wage gains on the debt of low-wage workers. In the three years following a \0.88 minimum wage increase, low-wage workers experience a \2,712 income increase and a $856 decrease in debt....
Persistent link: https://www.econbiz.de/10014535497
We examine individuals' decision to attend Black Lives Matter protests and demonstrations calling for less stringent public health measures to combat COVID-19 (e.g., for swifter reopening of businesses). Our analysis is facilitated by a unique staggered panel data set originally constructed to...
Persistent link: https://www.econbiz.de/10013448622
Health-maximizing and welfare-maximizing behaviors can be at odds, especially among disadvantaged groups, generating health disparities. We estimate a lifecycle model of medication and labor supply decisions using data on HIV-positive men. We evaluate an effective HIV treatment innovation that...
Persistent link: https://www.econbiz.de/10013453985
Many randomized experiments are plagued by attrition, even among subjects receiving more effective treatments. We estimate the subject's utility associated with the receipt of treatment, as revealed by dropout behavior, to evaluate treatment effects. Utility is a function of both "publicly...
Persistent link: https://www.econbiz.de/10005076452
Persistent link: https://www.econbiz.de/10007617553
Many randomized experiments are plagued by attrition, even among subjects receiving more effective treatments. We estimate the subject's utility associated with the receipt of treatment, as revealed by dropout behavior, to evaluate treatment effects. Utility is a function of both "publicly...
Persistent link: https://www.econbiz.de/10014053946